Fundraising FoxAdams Street Partners — 2020 Investments
5 investments dated 2020 · listed companies and verified rows first · show all
Identity verification technology using photo-based ID documents, selfies, and AI.
London
Husayn Kassai(Founder)inRuhul Amin(Founder)inRuhul Amin OBE(Founder)inEamon Jubbawy(Founder)Lila Tretikov(Director)David Clarke(Executive Officer, Director)
Board seatMike Zappert· per SEC Form D · $125.2M raise · filed Apr 2020
Co-investorsAcequia Capital (AceCap)AfterWork VenturesAugmentum FintechBY Venture PartnersFin CapitalForgePoint Capital+10 more
Aircall is an AI-powered cloud platform that combines intelligent voice agents, automated workflows, and real-time coaching for sales and support teams.
AI & Machine LearningCloud ComputingDeveloper ToolsEnterprise SoftwareSaaSNew York, US
Xavier Durand(Founder)inJonathan Anguelov(Founder)inOlivier Pailhes(Founder)inPierre-Baptiste Béchu(Founder)inQuentin Nickmans(Director)inScott Chancellor(CEO)in
Co-investors3founders500 GlobalBalderton CapitalDigital Leaders VenturesFJ LabsFundersClub+16 more
Included Health provides healthcare navigation and delivery services—including care guidance, billing and claims support, and virtual and in-person care spanning primary, behavioral, urgent, and specialty care—for employees and members of health plans and employers.
Digital HealthHealthtechMental HealthSan Francisco, US
Owen Tripp(Co-Founder & CEO)inLawrence Hofmann(Co-Founder, Grand Rounds)inAdam Jackson(Co-Founder, Doctor On Demand)Jay McGraw(Co-Founder, Doctor On Demand)Phil McGraw(Co-Founder, Doctor On Demand)Colin Quinn(Executive Officer, Director)in
Co-investorsACME CapitalAlpha PartnersB CapitalBlackRockFelicis VenturesGaingels+16 more
__Twitter.png)
Lyra provides mental health care services through a network of evidence-based providers, combining clinical expertise with technology to deliver accessible, quality care for employers and health plans.
Digital HealthEnterprise SoftwareHealthtechHR TechMental HealthBurlingame, US
David Ebersman(Founder)inBob Kocher(Co-Founder and Board Member)inDena Bravata(Founder)Alethea Varra(Vice President of Clinical Care)inJennifer Schulz(Chief Executive Officer)Elaine Yang(Executive Officer)in
Co-investorsAdditionBreyer CapitalCasdin CapitalCoatue ManagementDragoneer Investment GroupDurable Capital Partners+10 more
Orbus Therapeutics is a clinical-stage biopharmaceutical company developing eflornithine (DFMO), an oral ODC inhibitor, as a cancer therapy.
BiotechHealthtechAptos, US
Jason Levin(Founder, Director and Chief Executive Officer)Robert M. Myers(Executive Officer, Director)
BoardMichael Wasserman(Director)Patrick Enright(Director)inElisha (Terry) Gould(Director)Ernest Mario(Director)
Co-investorsH.I.G. BioHealth PartnersH.I.G. CapitalH.I.G. HealthBridge PartnersLongitude CapitalAbingworthAgent Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.